EP1140280A4 - Transdermal delivery of fine powders - Google Patents

Transdermal delivery of fine powders

Info

Publication number
EP1140280A4
EP1140280A4 EP99961255A EP99961255A EP1140280A4 EP 1140280 A4 EP1140280 A4 EP 1140280A4 EP 99961255 A EP99961255 A EP 99961255A EP 99961255 A EP99961255 A EP 99961255A EP 1140280 A4 EP1140280 A4 EP 1140280A4
Authority
EP
European Patent Office
Prior art keywords
transdermal delivery
fine powders
powders
fine
transdermal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
EP99961255A
Other languages
German (de)
French (fr)
Other versions
EP1140280B1 (en
EP1140280A1 (en
Inventor
Zohar Avrahami
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Syneron Medical Ltd
Original Assignee
TransPharma Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by TransPharma Ltd filed Critical TransPharma Ltd
Publication of EP1140280A1 publication Critical patent/EP1140280A1/en
Publication of EP1140280A4 publication Critical patent/EP1140280A4/en
Application granted granted Critical
Publication of EP1140280B1 publication Critical patent/EP1140280B1/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/18—Applying electric currents by contact electrodes
    • A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/327—Applying electric currents by contact electrodes alternating or intermittent currents for enhancing the absorption properties of tissue, e.g. by electroporation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/02—Details
    • A61N1/04—Electrodes
    • A61N1/0404—Electrodes for external use
    • A61N1/0472—Structure-related aspects
    • A61N1/0492—Patch electrodes
    • A61N1/0496—Patch electrodes characterised by using specific chemical compositions, e.g. hydrogel compositions, adhesives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/18—Applying electric currents by contact electrodes
    • A61N1/20—Applying electric currents by contact electrodes continuous direct currents
    • A61N1/30—Apparatus for iontophoresis, i.e. transfer of media in ionic state by an electromotoric force into the body, or cataphoresis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/18—Applying electric currents by contact electrodes
    • A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/325—Applying electric currents by contact electrodes alternating or intermittent currents for iontophoresis, i.e. transfer of media in ionic state by an electromotoric force into the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/02—Details
    • A61N1/04—Electrodes
    • A61N1/0404—Electrodes for external use
    • A61N1/0472—Structure-related aspects
    • A61N1/0476—Array electrodes (including any electrode arrangement with more than one electrode for at least one of the polarities)
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00—Nanotechnology
    • Y10S977/70—Nanostructure
    • Y10S977/773—Nanoparticle, i.e. structure having three dimensions of 100 nm or less
    • Y10S977/775—Nanosized powder or flake, e.g. nanosized catalyst
EP99961255.9A 1998-12-24 1999-12-22 Transdermal delivery of fine powders Expired - Lifetime EP1140280B1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US09/220,712 US5983135A (en) 1998-12-24 1998-12-24 Transdermal delivery of fine powders
PCT/IL1999/000696 WO2000038781A1 (en) 1998-12-24 1999-12-22 Transdermal delivery of fine powders
US220712 2005-01-04

Publications (3)

Publication Number Publication Date
EP1140280A1 EP1140280A1 (en) 2001-10-10
EP1140280A4 true EP1140280A4 (en) 2008-12-31
EP1140280B1 EP1140280B1 (en) 2016-11-16

Family

ID=22824639

Family Applications (1)

Application Number Title Priority Date Filing Date
EP99961255.9A Expired - Lifetime EP1140280B1 (en) 1998-12-24 1999-12-22 Transdermal delivery of fine powders

Country Status (7)

Country Link
US (1) US5983135A (en)
EP (1) EP1140280B1 (en)
JP (1) JP4382991B2 (en)
AU (1) AU760950B2 (en)
CA (1) CA2356175C (en)
IL (1) IL143857A0 (en)
WO (1) WO2000038781A1 (en)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6611706B2 (en) * 1998-11-09 2003-08-26 Transpharma Ltd. Monopolar and bipolar current application for transdermal drug delivery and analyte extraction
IL136008A0 (en) * 2000-05-07 2001-05-20 Elecsys Ltd Electrically-mediated transdermal drug injection
US7635488B2 (en) * 2001-03-13 2009-12-22 Dbv Technologies Patches and uses thereof
US6686207B2 (en) 2001-10-12 2004-02-03 Massachusetts Institute Of Technology Manipulating micron scale items
EP1499255B1 (en) * 2002-04-19 2015-07-22 Syneron Medical Ltd. Handheld transdermal drug delivery and analyte extraction
IL152575A (en) * 2002-10-31 2008-12-29 Transpharma Medical Ltd Transdermal delivery system for water insoluble drugs
US8133505B2 (en) * 2002-10-31 2012-03-13 Transpharma Medical Ltd. Transdermal delivery system for dried particulate or lyophilized medications
IL152573A (en) * 2002-10-31 2009-11-18 Transpharma Medical Ltd Transdermal delivery system for anti-emetic medication
IL152574A (en) * 2002-10-31 2009-09-22 Transpharma Medical Ltd Transdermal delivery system for dried particulate or lyophilized medications
US7383084B2 (en) * 2002-10-31 2008-06-03 Transpharma Medical Ltd. Transdermal delivery system for dried particulate or lyophilized medications
US7662404B2 (en) * 2002-10-31 2010-02-16 Transpharma Medical Ltd. Transdermal delivery system for dried particulate or lyophilized peptides and polypeptides
KR20050098277A (en) * 2003-01-29 2005-10-11 이-필 파마 리미티드 Active drug delivery in the gastrointestinal tract
US20040267240A1 (en) * 2003-01-29 2004-12-30 Yossi Gross Active drug delivery in the gastrointestinal tract
IL156789A0 (en) * 2003-07-06 2004-02-08 Adapter for multi-element contact-probe
IL159273A0 (en) * 2003-12-09 2004-06-01 Transpharma Medical Ltd Transdermal delivery system for sustained release of polypeptides
EP1742588B1 (en) 2004-04-01 2016-10-19 The General Hospital Corporation Apparatus for dermatological treatment and tissue reshaping
WO2006064502A2 (en) * 2004-12-14 2006-06-22 E-Pill Pharma, Ltd. Local delivery of drugs or substances using electronic permeability increase
JP2008540023A (en) * 2005-05-19 2008-11-20 イー−ピル ファーマ リミティド Ingestible device for nitric oxide production in tissues
WO2006131931A2 (en) * 2005-06-10 2006-12-14 Transpharma Medical, Ltd. Patch for transdermal drug delivery
JP4804904B2 (en) * 2005-12-09 2011-11-02 Ｔｔｉ・エルビュー株式会社 Iontophoresis device packaging
JP5466161B2 (en) * 2007-10-09 2014-04-09 トランスファーマ メディカル リミテッド Magnetic patch connector
WO2009050718A2 (en) * 2007-10-17 2009-04-23 Transpharma Medical Ltd. Dissolution rate verification
US20100293807A1 (en) * 2007-10-29 2010-11-25 Transpharma Medical, Ltd. Vertical patch drying
MX2010006062A (en) 2007-12-05 2010-09-14 Syneron Medical Ltd A disposable electromagnetic energy applicator and method of using it.
JP5461427B2 (en) * 2007-12-17 2014-04-02 ニューワールド ファーマシューティカルズ，エルエルシー Integrated intradermal delivery, diagnosis and communication system
KR101626167B1 (en) 2008-01-17 2016-05-31 시네론 메디컬 리미티드 A hair removal apparatus for personal use and the method of using same
JP2011509791A (en) 2008-01-24 2011-03-31 シネロン メディカル リミテッド Apparatus, device and method for adipose tissue treatment
WO2009148613A1 (en) * 2008-06-04 2009-12-10 Coda Therapeutics, Inc. Treatment of pain with gap junction modulation compounds
WO2010029552A1 (en) * 2008-09-10 2010-03-18 Transpharma Medical Ltd. Transdermal delivery of oligosaccharides
KR101523807B1 (en) 2008-09-21 2015-05-28 시네론 메디컬 리미티드 A method and apparatus for personal skin treatment
US8357150B2 (en) 2009-07-20 2013-01-22 Syneron Medical Ltd. Method and apparatus for fractional skin treatment
US8606366B2 (en) 2009-02-18 2013-12-10 Syneron Medical Ltd. Skin treatment apparatus for personal use and method for using same
US20100225490A1 (en) * 2009-03-05 2010-09-09 Leuthardt Eric C Postural information system and method including central determining of subject advisory information based on subject status information and postural influencer status information
US8414559B2 (en) 2009-05-07 2013-04-09 Rainbow Medical Ltd. Gastroretentive duodenal pill
US20100286587A1 (en) * 2009-05-07 2010-11-11 Yossi Gross Sublingual electrical drug delivery
EP3269372B1 (en) 2012-01-19 2019-06-12 Hybrid Medical, LLC Topical therapeutic formulations
JP2015513905A (en) 2012-03-27 2015-05-18 コーダ セラピューティクス， インコーポレイテッド Compositions and treatments based on cadherin regulation
CN104768567B (en) 2012-05-18 2017-07-11 奥塔哥创业有限公司 Therapeutic alliance and composition for wound healing

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1989006555A1 (en) * 1988-01-21 1989-07-27 Massachusetts Institute Of Technology Transport of molecules across tissue using electroporation

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5088977A (en) * 1988-12-21 1992-02-18 Drug Delivery Systems Inc. Electrical transdermal drug applicator with counteractor and method of drug delivery
US5304125A (en) * 1990-10-05 1994-04-19 The University Of North Carolina Apparatus for administering solid particulate aerosols to the lungs
US5310404A (en) * 1992-06-01 1994-05-10 Alza Corporation Iontophoretic delivery device and method of hydrating same
FR2709423B1 (en) * 1993-08-30 1995-11-17 Lhd Lab Hygiene Dietetique Reservoir impregnable with a solution of active principle, for an iontophoretic device for transdermal administration of medicaments, and method of manufacturing such a reservoir.

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1989006555A1 (en) * 1988-01-21 1989-07-27 Massachusetts Institute Of Technology Transport of molecules across tissue using electroporation

Also Published As

Publication number Publication date
EP1140280B1 (en) 2016-11-16
AU760950B2 (en) 2003-05-22
JP4382991B2 (en) 2009-12-16
AU1794800A (en) 2000-07-31
EP1140280A1 (en) 2001-10-10
IL143857A0 (en) 2002-04-21
CA2356175A1 (en) 2000-07-06
US5983135A (en) 1999-11-09
WO2000038781A1 (en) 2000-07-06
CA2356175C (en) 2011-10-11
JP2002533177A (en) 2002-10-08

Similar Documents

Publication Publication Date Title
IL143857A0 (en) Transdermal delivery of fine powders
HUP0202302A2 (en) Foaming ingredient and powders containing it
HK1061359A1 (en) Dosage form of powder agglomerates
IL133031A0 (en) Powder inhaler
AU5889398A (en) Powder inhaler
HK1040995A1 (en) 2-oxoquinoline compounds and medicinal uses thereof
EP1065675A4 (en) Ferromagnetic powder
GB2356204B (en) Self-bonding MCrA1Y powder
GB9826783D0 (en) Inhalation powders
EP0941039A4 (en) Transdermal administration of ment
EP1004296A4 (en) Powder containing fat-soluble drug
PL337723A1 (en) Inhalable tocopherol-stabilised prolyposomic powders
EP1095708A4 (en) Masking material
GB9701561D0 (en) Ceramic body
IL134135A0 (en) Electroconductive ceramic material
AU1143899A (en) Transdermal delivery of 3,4-diarylchromans
GB9815393D0 (en) Powder dispenser
GB2337052B (en) A composition comprising a fine powder
GB9803032D0 (en) Transdermal delivery devices
TW461309U (en) Improved structure of powder grinding device
GB0103901D0 (en) Material delivery devices and methods
GB9927525D0 (en) Delivery of substances
GB9928865D0 (en) Improved ceramic material
GB9724144D0 (en) Dispersion of powders
GB9421942D0 (en) Preparation of fine powder

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20010702

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

AX Request for extension of the european patent

Free format text: AL;LT;LV;MK;RO;SI

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: TRANSPHARMA LTD.

A4 Supplementary search report drawn up and despatched

Effective date: 20081127

RIC1 Information provided on ipc code assigned before grant

Ipc: A61N 1/30 20060101AFI20000711BHEP

Ipc: A61N 1/32 20060101ALI20081121BHEP

17Q First examination report despatched

Effective date: 20090218

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: SYNERON MEDICAL LTD.

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

INTG Intention to grant announced

Effective date: 20160527

GRAS Grant fee paid

Free format text: ORIGINAL CODE: EPIDOSNIGR3

GRAA (expected) grant

Free format text: ORIGINAL CODE: 0009210

AK Designated contracting states

Kind code of ref document: B1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

REG Reference to a national code

Ref country code: GB

Ref legal event code: FG4D

REG Reference to a national code

Ref country code: CH

Ref legal event code: EP

REG Reference to a national code

Ref country code: IE

Ref legal event code: FG4D

REG Reference to a national code

Ref country code: AT

Ref legal event code: REF

Ref document number: 845345

Country of ref document: AT

Kind code of ref document: T

Effective date: 20161215

REG Reference to a national code

Ref country code: FR

Ref legal event code: PLFP

Year of fee payment: 18

REG Reference to a national code

Ref country code: DE

Ref legal event code: R096

Ref document number: 69945665

Country of ref document: DE

REG Reference to a national code

Ref country code: DE

Ref legal event code: R096

Ref document number: 69945665

Country of ref document: DE

REG Reference to a national code

Ref country code: NL

Ref legal event code: MP

Effective date: 20161116

REG Reference to a national code

Ref country code: AT

Ref legal event code: MK05

Ref document number: 845345

Country of ref document: AT

Kind code of ref document: T

Effective date: 20161116

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20161116

Ref country code: NL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20161116

Ref country code: GR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20170217

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: ES

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20161116

Ref country code: AT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20161116

Ref country code: PT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20170316

Ref country code: FI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20161116

Ref country code: BE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20161231

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: DK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20161116

REG Reference to a national code

Ref country code: CH

Ref legal event code: PL

REG Reference to a national code

Ref country code: DE

Ref legal event code: R097

Ref document number: 69945665

Country of ref document: DE

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: BE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20161116

Ref country code: IT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20161116

PLBE No opposition filed within time limit

Free format text: ORIGINAL CODE: 0009261

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: MC

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20161116

REG Reference to a national code

Ref country code: IE

Ref legal event code: MM4A

26N No opposition filed

Effective date: 20170817

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: CH

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20161231

Ref country code: LI

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20161231

Ref country code: LU

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20161222

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20161222

REG Reference to a national code

Ref country code: FR

Ref legal event code: PLFP

Year of fee payment: 19

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: GB

Payment date: 20180228

Year of fee payment: 19

Ref country code: DE

Payment date: 20180228

Year of fee payment: 19

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: CY

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20161116

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: FR

Payment date: 20180312

Year of fee payment: 19

REG Reference to a national code

Ref country code: DE

Ref legal event code: R119

Ref document number: 69945665

Country of ref document: DE

GBPC Gb: european patent ceased through non-payment of renewal fee

Effective date: 20181222

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: FR

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20181231

Ref country code: DE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20190702

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: GB

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20181222